About us
Our Story
Founded in 2023, DAMOCLES Diagnostics emerged from the collaboration of six experts with complementary skills, ranging from clinical bacteriology to mechatronics, analytical chemistry, and in vitro diagnostics. Driven by a shared ambition to revolutionize medical diagnostics, the team joined forces to create an innovative company focused on the early detection of bacterial infections. DAMOCLES Diagnostics embodies teamwork and a diversity of talents.
Since its inception, we have filed a patent in Europe, the United States, and Canada, and published scientific articles in leading international journals.
2020
Intellectual Property
Filing of a technological patent
2022
University incubation
AVRUL Incubator
2023
Startup creation
DAMOCLES Diagnostics
Pre-seed funding round
€800K
2024
Our Team
Nicolas ROUSSELET
Pr Olivier Barraud
Dr Audrey Gauthier
Dr Gaëlle BEGAUD
Guillaume Bois-Salvaro
Pr serge battu
Our Partners
Our Awards
Our Scientific Publications
2024
GAUTHIER et al., 2024. Sedimentation Field Flow Fractionation for rapid phenotypic antimicrobial susceptibility testing: a pilot study. Journal of Antimicrobial Chemotherapy.
2023
GAUTHIER et al., 2023. Sedimentation Field-Flow Fractionation: A Diagnostic Tool for Rapid Antimicrobial Susceptibility Testing. Analytical Chemistry.